Merlin chief in discussions with SFO
Merlin Bioscience’s chief executive, Sir Christopher Evans, has been interviewed by the Serious Fraud Office as part of an investigation into allegations of fraud.
30 December 2012•1 min read
Merlin Bioscience’s chief executive, Sir Christopher Evans, has been interviewed by the Serious Fraud Office as part of an investigation into allegations of fraud.
Side Letter: Lazard CL launches
2 November 2026 · 3 mins read
Deep Dive: Why Asia-Pacific private equity is shifting from growth to control
2 November 2026 · 10 mins read
TPG targets Q4 close for latest flagship and healthcare fund
29 October 2026 · 2 mins read
Blue Owl's latest GP stakes fund close may slip to Q1 2027
29 October 2026 · 3 mins read
The largest funds take a growing share of total PE fundraising
29 October 2026 · 2 mins read
Side Letter: Mid-alignment
29 October 2026 · 3 mins read
Side Letter: Software stress
28 October 2026 · 3 mins read
